Article Text

Systematic review: blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia
  1. B McGuinness1,
  2. S Todd1,
  3. A P Passmore1,
  4. R Bullock2
  1. 1
    Department of Geriatric Medicine, Whitla Medical Building, Queen’s University Belfast, Belfast, UK
  2. 2
    Kingshill Research Centre, Victoria Hospital, Swindon, UK
  1. Dr B McGuinness, Department of Geriatric Medicine, Queen’s University Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast BT9 5HP, UK; b.mcguinness{at}

Statistics from


Hypertension and cognitive impairment are prevalent in older people. Hypertension is a direct risk factor for vascular dementia, and recent studies suggest hypertension also impacts on the prevalence of Alzheimer’s disease. The question is therefore whether treatment of hypertension lowers the rate of cognitive decline.


To assess the effects of blood pressure (BP) lowering treatments for the prevention of dementia and cognitive decline in patients with hypertension but no history of cerebrovascular disease.


Trials were identified through a search of the Cochrane Dementia and Cognitive Impairment Group’s Specialised Register which contains records from CENTRAL, MEDLINE, EMBASE, PsycINFO and CINAHL. Relevant journals were searched, drug companies, colleagues and researchers were contacted, and reference lists of all trials identified were screened.


Randomised, double blind, placebo controlled trials in which pharmacological or non-pharmacological interventions to lower BP were given for at least 6 months.


Two independent reviewers assessed trial …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.